Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Nausea drugs alleviate post-concussion headache pain

Written by | 13 Apr 2021

Article written by Bruce Sylvester. Treatment with two anti-nausea medications appears to alleviate headaches which took patients to the emergency room in the weeks after the initial injury…. read more.

Study reveals most effective drugs for common type of neuropathic pain

Written by | 25 Mar 2021

A novel psychological therapy that encourages addressing emotional experiences related to trauma, conflict and relationship problems has been found helpful for people with the chronic pain condition fibromyalgia.

GERPAC highlights 1: Cryopreservation of drugs – risk management

Written by | 16 Dec 2020

Article written by Christine Clark Storage of drug products at ultra-low temperatures calls for understanding of the special risks involved…

EU watchdog approves 10 new drugs

Written by | 3 Dec 2020

Article written by Gary Finnegan. The European Medicines Agency (EMA) has given the green light for ten new medicines at the latest meeting of its influential Committee for… read more.

Improved Trials of Rheumatology Drugs?

Written by | 12 Oct 2020

In a study by Rebecca Rothwell and colleagues, which appears in Arthritis & Rheumatology, possible considerations of non-inferiority (NI) trials assessing treatment effects in RA are discussed.

Dozens of blood pressure drugs do not elevate risk of depression

Written by | 9 Oct 2020

Article written by Bruce Sylvester Dozens of the most widely used blood pressure medications show no tendency to elevate risk of depression, Danish researchers report.

Statin use is not implicated in cognitive decline

Written by | 25 Nov 2019

Written by Bruce Sylvester Researchers report that there is no link between statin use and cognitive decline. The findings were published on Nov. 18, 2019 in the Journal… read more.

Translational oncology symposium

Written by | 18 Jul 2019

The use of tyrosine kinase inhibitors (TKIs) in the treatment of ALK-positive NSCLC is now well-established. Professor Ross Camidge (University of Colorado Cancer Centre, Denver, USA) described the lessons that… read more.

Brinavess refiled with FDA for recent onset atrial fibrillation – Correvio Pharma

Written by | 10 Jul 2019

Correvio Pharma has resubmitted a New Drug Application (NDA) to the US FDA seeking approval for Brinavess (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of adult patients with recent onset atrial fibrillation (AF).

UK impact of trial data

Written by | 8 Jul 2019

Dr Fiona McDonald (London, UK) discusses radical treatment for oligo metastatic NSCLC and if it should be the standard of care and Professor James Spicer (London, UK), the session Chair,  gives… read more.

Advances in RRMM

Written by | 9 May 2019

Professor Kwee Yong (London, UK) details the results from the Tourmaline-MM3 study

UEGW 2018: IBD: from epidemiology to costs and outcome

Written by | 1 Nov 2018

Dr Johan Burisch (Denmark) reviews data he presented on the cost saving effect of biological therapy in patients with IBD.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.